Company intelligence / Profile preview

bbi-biotech

Berlin, Berlin, Germany

Ownership: Private
Development stage: Other

Overview

bbi-biotech GmbH develops bioreactors, fermentors, and process equipment for biotechnology, pharma, food, and cosmetics sectors. Their solutions are used for both R&D and validated GMP production. Recent innovations include the xCUBIO modular bioreactor portfolio (for different cell and microbe cultivation), the bioPROBE automated sampling technology, and specialized systems for cell culture, microbial fermentation, and photobioreactor applications

Modalities: Device (bioreactors, fermenters, sampling systems)
Industry: Non-Drug Biotech

Partnerships

Xcellerex (GE Healthcare)Biostat (Sartorius)

Beyond the preview

Go deeper on bbi-biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on bbi-biotech.

Explore the full profile